Using a special dye to guide surgery for sarcoma removal

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the effectiveness of indocyanine green (ICG) dye and fluorescence technology during the surgical resection of bone and soft tissue sarcomas. Patients will receive ICG infusion prior to their scheduled surgery, and their medical records will be reviewed to assess the outcomes. The primary objective is to determine how well ICG can help confirm negative margins after tumor removal, potentially improving surgical precision and patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with biopsy-proven bone or soft tissue sarcoma undergoing resection

Exclusion Criteria:

* Chronic kidney disease
* Anaphylaxis to dyes

Where it's running

• Mayo Clinic in Rochester
  Rochester, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Matthew T. Houdek, M.D. — Mayo Clinic in Rochester
• Study coordinator: Clinical Trials Referral Office
• Email: mayocliniccancerstudies@mayo.edu
• Phone: 855-776-0015

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Preoperative Immunonutrition for bone and soft tissue sarcoma patients

  This study tests whether a short course of an oral nutrition supplement before surgery can help patients with bone or soft tissue sarcomas recover better after major tumor-related surgery.

  Recruiting St. Anne's University Hospital Brno, Czech Republic · Brno · NCT07609329

• Assessing early psychiatric referral effects on mental health in sarcoma patients

  This study tests whether getting early mental health support helps sarcoma patients feel less anxious and depressed while recovering from surgery.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 7 other locations · NCT06129903

• Evaluating quality of life and functional outcomes in sarcoma patients after limb salvage surgery

  This study looks at how limb salvage surgery affects the quality of life and daily functioning of people aged 18 to 95 who have had surgery for bone or soft tissue sarcoma in their legs.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven, Vlaams-Brabant · NCT05051059

• Quality assessment of sarcoma care in Europe and Latin America

  This study looks at how well patients with different types of sarcoma are treated in Europe and Latin America to see if care is better at expert centers and to find ways to improve outcomes.

  Recruiting at 7 sites Grupo Espanol de Investigacion en Sarcomas · Buenos Aires and 8 other locations · NCT04181970

• New method to deliver chemotherapy directly into the lungs for sarcoma patients

  This study is testing a new way to deliver chemotherapy directly into the lungs during surgery for sarcoma patients to see if it can better target hidden cancer cells and improve their outcomes.

  Recruiting Phase 1 University Health Network, Toronto · Toronto · NCT02811523

• 68Ga-HX01 PET/CT Imaging in Soft Tissue Sarcoma patients

  This study tests whether a 68Ga-HX01 injection can help PET/CT imaging better characterize soft tissue sarcoma in adults who have exhausted standard treatments or have no good options.

  Recruiting Phase 2 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd · Wuhan, Hubei · NCT07920835

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.